{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:07:45Z","timestamp":1762866465424},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s13277-014-2400-4","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T02:17:50Z","timestamp":1407118670000},"page":"10969-10975","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia"],"prefix":"10.1007","volume":"35","author":[{"given":"Kassogue","family":"Yaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehbi","family":"Hind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quachouh","family":"Meryem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quessar","family":"Asma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benchekroun","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadifi","family":"Sellama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"2400_CR1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2141.2000.02137.x","volume":"110","author":"CG Geary","year":"2000","unstructured":"Geary CG. The story of chronic myeloid leukaemia. Br J Haematol. 2000;110:2\u201311.","journal-title":"Br J Haematol"},{"key":"2400_CR2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1182\/blood-2002-09-2896","volume":"102","author":"S Branford","year":"2003","unstructured":"Branford S, Rudzki Z, Walsh S, Parkinson I, Grigg A, Szer J, et al. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood. 2003;102:276\u201383. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12623848 .","journal-title":"Blood"},{"key":"2400_CR3","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MWN Deininger","year":"2000","unstructured":"Deininger MWN, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343\u201356.","journal-title":"Blood"},{"key":"2400_CR4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.2003.11.143","volume":"21","author":"MW Deininger","year":"2003","unstructured":"Deininger MW, O\u2019Brien SG, Ford JM, Druker BJ. Practical management of patients with chronic myeloid leukemia receiving imatinib. J Clin Oncol: Off J Am Soc Clin Oncol. 2003;21:1637\u201347. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12668652 .","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"2400_CR5","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","volume":"105","author":"M Deininger","year":"2005","unstructured":"Deininger M, Buchdunger E, Druker BJ. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood. 2005;105:2640\u201353. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15618470 .","journal-title":"Blood"},{"key":"2400_CR6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2298\/SARH1006305C","volume":"138","author":"I Cojbasic","year":"2010","unstructured":"Cojbasic I, Macukanovic-Golubovic L. Prognostic factors associated with complete cytogenetic response in patients with chronic myelogenous leukemia on imatinib mesylate therapy. Srp Arh Celok Lek. 2010;138:305\u20138. Available from: http:\/\/www.doiserbia.nb.rs\/Article.aspx?ID=0370-81791006305C .","journal-title":"Srp Arh Celok Lek"},{"key":"2400_CR7","doi-asserted-by":"crossref","unstructured":"L\u00f6ffler H, Bergmann J, Hochhaus A, Hehlmann R, Kramer A, and the German CML Study Group. Reduced risk for chronic myelogenous leukemia in individuals with the cytochrome P-450 gene polymorphism CYP1A1*2A. Blood. 2001;98:3874\u20135. doi: 10.1182\/blood.V98.13.3874 .","DOI":"10.1182\/blood.V98.13.3874"},{"key":"2400_CR8","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.2307\/3578893","volume":"137","author":"DL Preston","year":"1994","unstructured":"Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950\u20131987. Radiat Res. 1994;137:S68\u201397. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8127953 .","journal-title":"Radiat Res"},{"key":"2400_CR9","first-page":"12","volume":"138","author":"M Taspinar","year":"2008","unstructured":"Taspinar M, Aydos SE, Comez O, Elhan AH, Karabulut HG, Sunguroglu A. CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukemia. Swiss Med Wkly. 2008;138:12\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18224491 .","journal-title":"Swiss Med Wkly"},{"key":"2400_CR10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1134\/S0006297908050076","volume":"73","author":"GA Belitsky","year":"2008","unstructured":"Belitsky GA, Yakubovskaya MG. Genetic polymorphism and variability of chemical carcinogenesis. Biochem Biokhimia. 2008;73:543\u201354. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18605979 .","journal-title":"Biochem Biokhimia"},{"key":"2400_CR11","doi-asserted-by":"crossref","unstructured":"Lee JS, Ward WO, Liu J, Ren H, Vallanat B, Delker D, et al. Hepatic xenobiotic metabolizing enzyme and transporter gene expression through the life stages of the mouse. PloS one. 2011;6:e24381. Available from","DOI":"10.1371\/journal.pone.0024381"},{"key":"2400_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2133\/dmpk.21.257","volume":"21","author":"T Shimada","year":"2006","unstructured":"Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet. 2006;21:257\u201376.","journal-title":"Drug Metab Pharmacokinet"},{"key":"2400_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.physiol.65.092101.142528","volume":"65","author":"GA Francis","year":"2003","unstructured":"Francis GA, Fayard E, Picard F, Auwerx J. Nuclear receptors and the control of metabolism. Annu Rev Physiol. 2003;65:261\u2013311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12518001 .","journal-title":"Annu Rev Physiol"},{"key":"2400_CR14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0300-483X(02)00297-4","volume":"181","author":"MF Fromm","year":"2002","unstructured":"Fromm MF. Genetically determined differences in P-glycoprotein function: implications for disease risk. Toxicology. 2002;181:299\u2013303. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12505329 .","journal-title":"Toxicology"},{"key":"2400_CR15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02977789","volume":"28","author":"C Xu","year":"2005","unstructured":"Xu C, Li CY-T, Kong A-NT. Induction of phase I, II and III drug metabolism\/transport by xenobiotics. Arch Pharm Res. 2005;28:249\u201368. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15832810 .","journal-title":"Arch Pharm Res"},{"key":"2400_CR16","doi-asserted-by":"crossref","first-page":"17432","DOI":"10.1016\/S0021-9258(18)45397-5","volume":"262","author":"K Ueda","year":"1987","unstructured":"Ueda K, Pastan I, Ottesman MM. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J Biol Chem. 1987;262:17432\u20136.","journal-title":"J Biol Chem"},{"key":"2400_CR17","doi-asserted-by":"crossref","unstructured":"Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA. 1987;84:265\u20139. Available from","DOI":"10.1073\/pnas.84.1.265"},{"key":"2400_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/37.2.2463300","volume":"37","author":"F Thiebaut","year":"1989","unstructured":"Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem. 1989;37:159\u201364. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2463300 .","journal-title":"J Histochem Cytochem"},{"key":"2400_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.19.1","volume":"19","author":"T Ishikawa","year":"2004","unstructured":"Ishikawa T, Hirano H, Onishi Y, Sakurai A, Tarui S. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses. Drug Metab Pharmacokinet. 2004;19:1\u201314. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15499164 .","journal-title":"Drug Metab Pharmacokinet"},{"key":"2400_CR20","doi-asserted-by":"crossref","unstructured":"Andersen V, Ostergaard M, Christensen J, Overvad K, Tj\u00f8nneland A, Vogel U. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer. 2009;9:407. doi: 10.1186\/1471-2407-9-407 .","DOI":"10.1186\/1471-2407-9-407"},{"key":"2400_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-13-57","volume":"13","author":"M Brinar","year":"2013","unstructured":"Brinar M, Cukovic-Cavka S, Bozina N, Ravic KG, Markos P, Ladic A, et al. MDR1 polymorphisms are associated with inflammatory bowel disease in a cohort of Croatian IBD patients. BMC Gastroenterol. 2013;13:1\u20137.","journal-title":"BMC Gastroenterol"},{"key":"2400_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-9-407","volume":"9","author":"V Andersen","year":"2009","unstructured":"Andersen V, Ostergaard M, Christensen J, Overvad K, Tj\u00f8nneland A, Vogel U. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer. 2009;9:1\u201311.","journal-title":"BMC Cancer"},{"key":"2400_CR23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.2004.00228.x","volume":"72","author":"K Jamroziak","year":"2004","unstructured":"Jamroziak K, M\u0142ynarski W, Balcerczak E, Mistygacz M, Trelinska J, Mirowski M, et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol. 2004;72:314\u201321. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15059065 .","journal-title":"Eur J Haematol"},{"key":"2400_CR24","first-page":"123","volume":"19","author":"DM Elghannam","year":"2013","unstructured":"Elghannam DM, Ibrahim L, Ebrahim MA, Azmy E, Hakem H. Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients. Hematol (Amsterdam, Netherlands). 2013;19:123\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23683876 .","journal-title":"Hematol (Amsterdam, Netherlands)"},{"key":"2400_CR25","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","volume":"16","author":"S Miller","year":"1988","unstructured":"Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.","journal-title":"Nucleic Acids Res"},{"key":"2400_CR26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1089\/dna.2013.2108","volume":"32","author":"Y Kassogue","year":"2013","unstructured":"Kassogue Y, Dehbi H, Nassereddine S, Quachouh M, Nadifi S. Genotype variability and haplotype frequency of MDR1 (ABCB1) gene polymorphism in Morocco. DNA Cell Biol. 2013;32:582\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23930592 .","journal-title":"DNA Cell Biol"},{"key":"2400_CR27","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/bioinformatics\/btl268","volume":"22","author":"X Sol\u00e9","year":"2006","unstructured":"Sol\u00e9 X, Guin\u00f3 E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinforma (Oxford, England). 2006;22:1928\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16720584 .","journal-title":"Bioinforma (Oxford, England)"},{"key":"2400_CR28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","volume":"75","author":"C Marzolini","year":"2004","unstructured":"Marzolini C, Paus E, Buclin T, Kim R. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther. 2004;75:13\u201333.","journal-title":"Clin Pharmacol Ther"},{"key":"2400_CR29","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1182\/blood.V91.5.1749","volume":"91","author":"LA Mickley","year":"1998","unstructured":"Mickley LA, Lee JS, Weng Z, Zhan Z, Alvarez M, Wilson W, et al. Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors. Blood. 1998;91:1749\u201356. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9473242 .","journal-title":"Blood"},{"key":"2400_CR30","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1131262","volume":"314","author":"AG Nackley","year":"2006","unstructured":"Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science (New York, NY). 2006;314:1930\u20133. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17185601 .","journal-title":"Science (New York, NY)"},{"key":"2400_CR31","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1158\/0008-5472.CAN-07-2377","volume":"67","author":"ZE Sauna","year":"2007","unstructured":"Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res. 2007;67:9609\u201312. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17942888 .","journal-title":"Cancer Res"},{"key":"2400_CR32","first-page":"564","volume":"87","author":"RT Calado","year":"2002","unstructured":"Calado RT, Falc\u00e3o RP, Garcia AB, Gabellini SM, Zago MA, Franco RF. Influence of functional MDR1 gene polymorphisms on P-glycoprotein activity in CD34+ hematopoietic stem cells. Haematologica. 2002;87:564\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12031911 .","journal-title":"Haematologica"},{"key":"2400_CR33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00008571-200106000-00003","volume":"11","author":"M Hitzl","year":"2001","unstructured":"Hitzl M, Drescher S, van der Kuip H, Sch\u00e4ffeler E, Fischer J, Schwab M, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics. 2001;11:293\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11434506 .","journal-title":"Pharmacogenetics"},{"key":"2400_CR34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bcmd.2011.11.001","volume":"48","author":"D Vivona","year":"2012","unstructured":"Vivona D, Bueno CT, Lima LT, Hirata RDC, Hirata MH, Luchessi AD, et al. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells Mol Dis. 2012;48:132\u20136. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22134106 .","journal-title":"Blood Cells Mol Dis"},{"key":"2400_CR35","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1158\/1055-9965.EPI-07-0007","volume":"16","author":"KY Urayama","year":"2007","unstructured":"Urayama KY, Wiencke JK, Buffler PA, Chokkalingam AP, Metayer C, Wiemels JL. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomark Prev. 2007;16:1172\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17548681 .","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2400_CR36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.leukres.2008.06.008","volume":"33","author":"K Jamroziak","year":"2009","unstructured":"Jamroziak K, Balcerczak E, Calka K, Piaskowski S, Urbanska-Rys H, Salagacka A, et al. Polymorphisms and haplotypes in the multidrug resistance 1 gene (MDR1\/ABCB1) and risk of multiple myeloma. Leuk Res. 2009;33:332\u20135. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18639335 .","journal-title":"Leuk Res"},{"key":"2400_CR37","first-page":"17","volume":"2","author":"K Sailaja","year":"2010","unstructured":"Sailaja K, Surekha D, Rao DN, Raghunadharao D. Association of MDR1 gene polymorphism (G2677T) with chronic myeloid leukemia. Biol Med. 2010;2:17\u201321.","journal-title":"Biol Med"},{"key":"2400_CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1179\/1607845413Y.0000000102","volume":"19","author":"D Elghannam","year":"2014","unstructured":"Elghannam D, Ibrahim L, Ebrahim M, Azmy E, Hakem H. Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients. Hematology. 2014;19:123\u20138.","journal-title":"Hematology"},{"key":"2400_CR39","first-page":"720","volume":"58","author":"K Jamroziak","year":"2006","unstructured":"Jamroziak K, Balcerczak E, Smolewski P, Robey RW, Cebula B, Panczyk M, et al. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacol Rep. 2006;58:720\u20138.","journal-title":"Pharmacol Rep"},{"key":"2400_CR40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mcp.2001.117412","volume":"70","author":"R Kim","year":"2001","unstructured":"Kim R, Leake B, Choo E, Dresser G, Kubba S, Schwarz U, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther. 2001;70:189\u201399.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2400-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2400-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2400-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T14:40:22Z","timestamp":1649860822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2400-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2400"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2400-4","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]}}}